These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 25639825

  • 21. Prognosis in liver transplantation recipients after hepatitis B virus recurrence.
    Sun LY, Zhu ZJ, Qu W, Sun XY, Rao W, Liu Y.
    Hepatogastroenterology; 2014 Oct; 61(135):2047-51. PubMed ID: 25713909
    [Abstract] [Full Text] [Related]

  • 22. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M, Ghobrial RM, Carmody IC, Anselmo DM, Farmer DG, Yersiz H, Chen P, Dawson S, Durazo F, Han S, Goldstein LI, Saab S, Hiatt J, Busuttil RW.
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [Abstract] [Full Text] [Related]

  • 23. Effect of occult hepatitis B virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis C virus infection.
    Nakano M, Kawaguchi T, Nakamoto S, Kawaguchi A, Kanda T, Imazeki F, Kuromatsu R, Sumie S, Satani M, Yamada S, Torimura T, Kakuma T, Yokosuka O, Sata M.
    Oncol Rep; 2013 Nov; 30(5):2049-55. PubMed ID: 23982634
    [Abstract] [Full Text] [Related]

  • 24. Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues.
    Campsen J, Zimmerman M, Trotter J, Hong J, Freise C, Brown R, Cameron A, Ghobrial M, Kam I, Busuttil R, Saab S, Holt C, Emond J, Stiles J, Lukose T, Chang M, Klintmalm G.
    Liver Transpl; 2013 Sep; 19(9):1020-9. PubMed ID: 23852663
    [Abstract] [Full Text] [Related]

  • 25. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
    Edamoto Y, Tani M, Kurata T, Abe K.
    Cancer; 1996 May 01; 77(9):1787-91. PubMed ID: 8646675
    [Abstract] [Full Text] [Related]

  • 26. Liver transplantation for HBV-related cirrhosis in Europe: an ELTR study on evolution and outcomes.
    Burra P, Germani G, Adam R, Karam V, Marzano A, Lampertico P, Salizzoni M, Filipponi F, Klempnauer JL, Castaing D, Kilic M, Carlis LD, Neuhaus P, Yilmaz S, Paul A, Pinna AD, Burroughs AK, Russo FP.
    J Hepatol; 2013 Feb 01; 58(2):287-96. PubMed ID: 23099188
    [Abstract] [Full Text] [Related]

  • 27. [The relationship between hepatocellular carcinoma recurrence and hepatitis B virus recurrence after liver transplantation].
    Li MR, Yi SH, Cai CJ, Yi HM, An YL, Wei M, Chen GH.
    Zhonghua Gan Zang Bing Za Zhi; 2011 Apr 01; 19(4):271-4. PubMed ID: 21586225
    [Abstract] [Full Text] [Related]

  • 28. Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B- or hepatitis C-related hepatocellular carcinoma.
    Sasaki Y, Yamada T, Tanaka H, Ohigashi H, Eguchi H, Yano M, Ishikawa O, Imaoka S.
    Ann Surg; 2006 Nov 01; 244(5):771-80. PubMed ID: 17060771
    [Abstract] [Full Text] [Related]

  • 29. The impact of viral hepatitis-related hepatocellular carcinoma to post-transplant outcomes.
    Younossi ZM, Stepanova M, Saab S, Ahmed A, Lam B, Srishord M, Venkatesan C, Wai H, Henry L.
    J Viral Hepat; 2016 Jan 01; 23(1):53-61. PubMed ID: 26289820
    [Abstract] [Full Text] [Related]

  • 30. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH, Wu JC, Chen CH, Chang TT, Lee PC, Chau GY, Lui WY, Chang FY, Lee SD.
    Liver Int; 2005 Apr 01; 25(2):236-41. PubMed ID: 15780044
    [Abstract] [Full Text] [Related]

  • 31. HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma.
    Sohn W, Paik YH, Kim JM, Kwon CH, Joh JW, Cho JY, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    Ann Surg Oncol; 2014 Jul 01; 21(7):2429-35. PubMed ID: 24619495
    [Abstract] [Full Text] [Related]

  • 32. Extended survival of patients with persistently suppressed hepatitis B transplanted for hepatocellular carcinoma.
    Viganò M, Bhoori S, Lampertico P, Donato MF, Iavarone M, Grossi G, Facciorusso A, Caccamo L, Rossi G, Colombo M, Mazzaferro V.
    Liver Int; 2015 Sep 01; 35(9):2187-93. PubMed ID: 25809541
    [Abstract] [Full Text] [Related]

  • 33. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
    Chung GE, Kim W, Lee JH, Kim YJ, Yoon JH, Lee JM, Lee JY, Kim SH, Kim D, Lee HS.
    J Gastroenterol Hepatol; 2011 Nov 01; 26(11):1638-45. PubMed ID: 22011297
    [Abstract] [Full Text] [Related]

  • 34. Hepatocellular Carcinoma in the Setting of Chronic Hepatitis B Virus Infection: Tumor Recurrence and Survival Rates After Liver Transplantation.
    Dugum M, Hanouneh I, Lopez R, Aucejo F, Eghtesad B, Zein N.
    Transplant Proc; 2015 Nov 01; 47(6):1939-44. PubMed ID: 26293077
    [Abstract] [Full Text] [Related]

  • 35. Hepatitis C virus infection is a risk factor for tumor recurrence after resection of small hepatocellular carcinomas.
    Huo TI, Wu JC, Hsia CY, Chau GY, Lui WY, Huang YH, Lee PC, Chang FY, Lee SD.
    World J Surg; 2004 Aug 01; 28(8):787-91. PubMed ID: 15457359
    [Abstract] [Full Text] [Related]

  • 36. Hepatitis B and hepatocellular carcinoma recurrence after living donor liver transplantation: The role of the Milan criteria.
    Vatansever S, Farajov R, Yılmaz HC, Zeytunlu M, Paköz ZB, Kılıç M.
    Turk J Gastroenterol; 2019 Jan 01; 30(1):75-80. PubMed ID: 30644364
    [Abstract] [Full Text] [Related]

  • 37. Liver transplantation for hepatocellular carcinoma within Milan Criteria in patients with Model for End-Stage Liver Disease score below 15: the impact of the etiology of cirrhosis on long-term survival.
    Tandoi F, Ponte E, Saffioti MC, Patrono D, Mirabella S, Lupo F, Romagnoli R, Salizzoni M.
    Transplant Proc; 2013 Sep 01; 45(7):2711-4. PubMed ID: 24034029
    [Abstract] [Full Text] [Related]

  • 38. Characteristics and outcome of patients with dual hepatitis B and C-associated hepatocellular carcinoma: are they different from patients with single virus infection?
    Huo TI, Huang YH, Hsia CY, Su CW, Lin HC, Hsu CY, Lee PC, Lui WY, Loong CC, Chiang JH, Chiou YY, Lee SD.
    Liver Int; 2009 May 01; 29(5):767-73. PubMed ID: 19018974
    [Abstract] [Full Text] [Related]

  • 39. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
    Young K, Aguilar M, Gish R, Younossi Z, Saab S, Bhuket T, Liu B, Ahmed A, Wong RJ.
    Liver Transpl; 2016 Oct 01; 22(10):1356-66. PubMed ID: 27348270
    [Abstract] [Full Text] [Related]

  • 40. Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.
    Saab S, Yeganeh M, Nguyen K, Durazo F, Han S, Yersiz H, Farmer DG, Goldstein LI, Tong MJ, Busuttil RW.
    Liver Transpl; 2009 Nov 01; 15(11):1525-34. PubMed ID: 19877207
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.